Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 9, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single-Cell

Tian Xia1, Ruiting Wen1, Guocai Wu1

  • 1Department of Hematology, Zhanjiang Central People's Hospital, Zhanjiang, Guangdong, China.

International Journal of Genomics
|June 8, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthy birth after chemotherapy for diffuse large B-cell lymphoma with superior vena cava syndrome in late pregnancy: A case report.

SAGE open medical case reports·2026
Same author

The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression.

Cancer research·2023
Same author

The Neuropilin-1 Ligand, Sema3A, Acts as a Tumor Suppressor in the Pathogenesis of Acute Leukemia.

Anatomical record (Hoboken, N.J. : 2007)·2018
Same author

Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.

Anatomical record (Hoboken, N.J. : 2007)·2018

This study identifies specific genes that causally influence acute myeloid leukemia (AML) risk. Some genes protect against AML, while others increase risk, offering new therapeutic targets.

Area of Science:

  • Genetics
  • Hematology
  • Oncology

Background:

  • Acute myeloid leukemia (AML) is a complex blood cancer with poorly understood genetic causes.
  • Identifying genetic factors linked to AML is key for developing effective treatments.

Purpose of the Study:

  • To investigate the causal relationships between genetic factors and AML risk.
  • To explore gene expression patterns in AML at the single-cell level.

Main Methods:

  • Mendelian randomization (MR) analysis was used to assess 10 genetic exposures and AML risk.
  • Multiple MR methods (IVW, weighted median, etc.) were employed for robust analysis.
  • Single-cell RNA sequencing was performed to analyze gene expression and cellular heterogeneity in AML.
Keywords:
Mendelian randomizationacute myeloid leukemiacausal inferencegenetic risk factorssingle-cell RNA sequencing

More Related Videos

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Related Experiment Videos

Last Updated: Jun 9, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Main Results:

  • MR analysis identified genes with protective effects (e.g., COL11A2, MTHFD1, SERPINA10) and risk-increasing effects (e.g., PDE5A, SPATA20).
  • PDE5A showed the strongest association with increased AML risk (OR > 8.0).
  • Single-cell analysis revealed distinct cell populations and cell-specific expression of identified risk genes.

Conclusions:

  • This study provides strong evidence for causal genetic links to AML risk.
  • Findings offer insights into AML pathogenesis and identify potential cellular-level therapeutic targets.